Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage

These results demonstrate that iNOS inhibition does not protect against Ang II-induced end-organ damage, while EPA treatment does. Our electromobility shift assay experiments revealed that EPA protection may involve inhibition of AP-1- and NF-κB-dependent pathways.